Start the conversation
Last week, I told you how my "Best in Breed" (BIB) model identifies sectors – and the strongest stocks within those sectors – that may not be on everyone's radar.
It's evident in this "page-view" world that, unless your name is Amazon Inc. (Nasdaq: AMZN), Facebook Inc. (Nasdaq: FB) or Netflix Inc. (Nasdaq: NFLX) or your market cap is heading to the magical $1 trillion level, you're going to have a tough time getting noticed.
I beg to differ.
It's often the overlooked that outperform. And if you can jump aboard before the stock or sector grabs headlines, you can ride the ensuing buying wave to even greater profits.
However, the BIB model takes this process one step further. Using proprietary indicators, it identifies sectors that are up-and-comers. They may not be outperforming the broader market quite yet, but strength is brewing.
My model looks inside the sector at individual company strength trends. When I see several of my indicators pointing in the same direction, I know the sector is on the cusp of breaking out.
And getting aboard at that point – before the outperformance – gives me even greater profit potential.
Last week, I told you how the biotech sector was outperforming the best of the major market averages – the Nasdaq and small caps.
This week's sector can't make such a claim… yet. In fact, it's lagging the performance of the S&P 500 so far this year, which itself is trailing far behind tech and the small caps.
But that doesn't mean we can't still make a killing…
About the Author
Chris Johnson is a highly regarded equity and options analyst who has spent much of his nearly 30-year market career designing and interpreting complex models to help investment firms transform millions of data points into impressive gains for clients.
At heart Chris is a quant - like the "rocket scientists" of investing - with a specialty in applying advanced mathematics like stochastic calculus, linear algebra, differential equations, and statistics to Wall Street's data-rich environment.
He began building his proprietary models in 1998, analyzing about 2,000 records per day. Today, that database, which Chris designed and coded from scratch, analyzes a staggering 700,000 records per day. It's the secret behind his track record.
Chris holds degrees in finance, statistics, and accounting. He worked as a licensed broker for 11 years before taking on the role of Director of Quantitative Analysis at a big-name equity and options research firm for eight years. He recently served as Director of Research of a Cleveland-based investment firm responsible for hundreds of millions in AUM. He is also the Founder/CIO of ETF Advisory Research Partners since 2007, noted for its groundbreaking work in Behavioral Valuation systems. Their research is widely read by leaders in the RIA business.
Chris is ranked in the top 99.3% of financial bloggers and top 98.6% of overall experts by TipRanks, the track record registry of financial analysts dating back to January 2009.
He is a frequent commentator on financial markets for CNBC, Fox, Bloomberg TV, and CBS Radio and has been featured in Barron's, USA Today, Newsweek, and The Wall Street Journal, and numerous books.
Today, Chris is the editor of Night Trader and Strikepoint Trader and contributes to Money Morning as the Quant Analysis Specialist.